SGLT-2 inhibitors

DRUG6 trials

Conditions

Acute Ischemic StrokeAtrial Fibrillation (AF)DiabetesDiabetes Mellitus, Type 2Enlarged HeartHeart AttackHypertensionImpact of SGLT2-inhibitors on PC-AKI in ACS Patients Receiving Invasive Strategy

Phase 2

Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI

RecruitingNCT05305911

Minneapolis Heart Institute FoundationEnlarged Heart, Heart Attack

Start: 2022-08-03End: 2028-12-31Target: 81Updated: 2024-10-08

SGLT2i Improve Left Atrial Function in Patients With Paroxysmal Atrial Fibrillation, Hypertension and Abnormal Glucose Metabolism

RecruitingNCT07482020

Huashan HospitalAtrial Fibrillation (AF), Hypertension

Start: 2025-03-01End: 2027-06-30Target: 66Updated: 2026-03-19

Phase 3

SLGT2i for Neuroprotection in Patients With Acute Ischemic Stroke

Not yet recruitingNCT07105917

Second Affiliated Hospital, School of Medicine, Zhejiang UniversityAcute Ischemic Stroke

Start: 2025-08-01End: 2026-11-01Target: 1050Updated: 2025-08-11

Phase 4

Efficacy in Controlling Glycaemia With Victoza® (Liraglutide) as add-on to Metformin vs. OADs as add-on to Metformin After up to 104 Weeks of Treatment in Subjects With Type 2 Diabetes

CompletedNCT02730377

Novo Nordisk A/SDiabetes, Diabetes Mellitus, Type 2

Start: 2016-03-28End: 2019-08-12Updated: 2020-07-07

Unknown Phase

The Triglyceride/Glucose Index and SGLT-2 Inhibitors

CompletedNCT05915884

Samsun Education and Research HospitalDiabetes, Metabolic Disease

Start: 2023-06-10End: 2024-01-28Updated: 2024-04-26

SGLT2-inhibitors on PC-AKI

Active, not recruitingNCT06491953

Shenyang Northern HospitalImpact of SGLT2-inhibitors on PC-AKI in ACS Patients Receiving Invasive Strategy

Start: 2024-06-01End: 2026-05-28Target: 3600Updated: 2025-09-10

Related Papers

Maintenance of glycaemic control with liraglutide versus oral antidiabetic drugs as add‐on therapies in patients with type 2 diabetes uncontrolled with metformin alone: A randomized clinical trial in primary care ( <scp>LIRA‐PRIME</scp> )

Diabetes Obesity and Metabolism2021-10-0914 citations

922-P: LIRA-PRIME: A Randomized Trial in Primary Care Settings of Liraglutide vs. OAD for Glycemic Control in Patients with Type 2 Diabetes Not in Control on Metformin

Diabetes2020-06-011 citations

LIRA-PRIME Trial Design and Baseline Data—Efficacy in Controlling Glycemia with Liraglutide in a Primary Care Setting

Diabetes2018-06-22